Latest On BioCryst Pharmaceuticals, Inc (BCRX):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-31 17:21 EST | News | BioCryst Pharmaceuticals: An Updated View | N/A |  |
| 2023-05-03 21:24 EST | News | BioCryst Pharmaceuticals, Inc. 2023 Q1 - Results - Earnings Call Presentation | N/A | |
| 2023-05-03 21:24 EST | News | BioCryst Pharmaceuticals, Inc. (BCRX) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-03 21:24 EST | News | BioCryst gains 14% most since February after Q1 2023 results | N/A | |
| 2023-05-03 08:06 EST | News | BioCryst Pharmaceuticals GAAP EPS of -$0.28 beats by $0.03, revenue of $68.78M misses by $2.66M | N/A | |
| 2023-04-18 20:53 EST | News | BioCryst secures five-year credit facility | N/A | |
| 2023-04-12 14:45 EST | News | The Big Short: 5 Stocks At Risk With High Short Interest | N/A | |
| 2023-03-17 06:01 EST | News | BioCryst's Commercialization Of Orladeyo: Risks Materializing, A Shorting Opportunity | N/A | |
| 2023-03-08 22:50 EST | News | BioCryst: Good Candidate For Buyout, But Not For Anything Else | N/A | |
| 2023-03-08 22:50 EST | News | BioCryst wins Canadian nod for Orladeyo reimbursement | N/A | |
| 2023-03-02 13:37 EST | News | BioCryst Pharmaceuticals (BCRX) Presents At J.P. MORGAN HEALTHCARE CONFERENCE | N/A | |
| 2023-02-22 23:25 EST | News | BioCryst adds 13% to rebound as Needham upgrades; says selloff overdone | N/A | |
| 2023-02-22 10:26 EST | News | BioCryst Is Not Currently Uncovering The Full Value Of ORLADEYO | N/A | |
| 2023-02-21 21:57 EST | News | BioCryst at nine-month low as Q4 bottom-line disappoints | N/A | |
| 2023-02-21 21:57 EST | News | BioCryst Pharmaceuticals, Inc. (BCRX) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-21 21:57 EST | News | BioCryst Pharmaceuticals, Inc. 2022 Q4 - Results - Earnings Call Presentation | N/A | |
| 2023-02-21 08:13 EST | News | BioCryst Pharmaceuticals Non-GAAP EPS of -$0.38 misses by $0.18, revenue of $79.5M beats by $5.32M | N/A | |
| 2023-02-20 19:27 EST | News | BioCryst Pharmaceuticals Q4 2022 Earnings Preview | N/A | |
| 2023-02-04 07:22 EST | News | BioCryst Pharmaceuticals: An Overview Of Orladeyo For Hereditary Angioedema | N/A | |
| 2023-01-23 12:51 EST | News | BioCryst teams up with Swixx to sell Orladeyo in Central, Eastern Europe | N/A | |
| 2023-01-09 13:46 EST | News | BioCryst drops as sales for hereditary angioedema therapy lag forecasts | N/A | |
| 2022-12-21 02:03 EST | News | BioCryst Pharmaceuticals: More Aggressive Growth For Orladeyo | N/A | |
| 2022-12-16 00:24 EST | News | BioCryst drops on plans to discontinue oral Factor D inhibitor | N/A | |
| 2022-12-16 00:22 EST | News | BioCryst strategic interest likely to rise after oral Factor D inhibitor decision - Cowen | N/A | |
| 2022-12-06 15:56 EST | News | Bad flu season turned even worse around Thanksgiving - CDC | N/A | |
| 2022-11-15 15:48 EST | News | BioCryst Pharmaceuticals (BCRX) Investor Presentation -Slideshow | N/A | |
| 2022-11-04 16:23 EST | News | Fewer Americans have received the flu shot compared to same time last year - CDC | N/A | |
| 2022-11-02 13:59 EST | News | BioCryst rebounds as Evercore ISI upgrades after earnings day selloff | N/A | |
| 2022-11-01 22:53 EST | News | BioCryst Pharmaceuticals reports Q3 earnings beat; updates FY22 guidance | N/A | |
| 2022-11-01 22:53 EST | News | BioCryst Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call Presentation | N/A | |
| 2022-11-01 22:53 EST | News | BioCryst Pharmaceuticals, Inc. (BCRX) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-01 22:52 EST | News | BioCryst falls 11% despite Q3 beat (update) | N/A | |
| 2022-10-28 13:05 EST | News | Flu season off to a strong and early start, CDC data finds | N/A | |
| 2022-10-11 12:49 EST | News | BioCryst Pharmaceuticals: Working To Increase Market Presence Of Orladeyo | N/A | |
| 2022-09-14 19:02 EST | News | BioCryst Pharmaceuticals promotes Sheridan to development chief | N/A | |
| 2022-08-31 10:00 EST | News | BioCryst wins FDA’s Orphan Drug status for bone disorder therapy | N/A | |
| 2022-08-26 17:59 EST | News | BioCryst's BCX9930 for rare kidney disorder shows promise in early-stage study | N/A | |
| 2022-08-25 09:20 EST | News | BioCryst to supply 10K doses of influenza drug Rapivab to US for ~$7M | N/A | |
| 2022-08-18 07:38 EST | News | BioCryst Orladeyo gets approval in Saudi Arabia to prevent hereditary angioedema attacks | N/A | |
| 2022-08-04 23:49 EST | News | BioCryst Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call Presentation | N/A | |
| 2022-08-04 23:49 EST | News | BioCryst adds 16% as FDA lifts clinical hold on kidney disease program | N/A | |
| 2022-08-04 23:48 EST | News | BioCryst Pharmaceuticals, Inc. (BCRX) CEO Jon Stonehouse on Q2 Results - Earnings Call Transcript | N/A | |
| 2022-08-04 08:14 EST | News | BioCryst Pharmaceuticals GAAP EPS of -$0.32 beats by $0.03, revenue of $65.53M beats by $1.7M | N/A | |
| 2022-08-03 17:46 EST | News | BioCryst Pharmaceuticals Q2 2022 Earnings Preview | N/A | |
| 2022-07-26 00:41 EST | News | BioCryst Pharmaceuticals: Waiting For Clarity | N/A | |
| 2022-06-24 22:18 EST | News | BioCryst: A Prudent Diversification | N/A | |
| 2022-06-19 14:18 EST | News | BioCryst Pharmaceuticals (BCRX) Investor Presentation - Slideshow | N/A | |
| 2022-06-10 13:01 EST | News | BioCryst collaborates with Pint Pharma to sell Orladeyo in Latin America | N/A | |
| 2022-06-08 15:55 EST | News | BioCryst nabs FDA’s Fast Track status for candidate targeting rare bone forming disorder | N/A | |
| 2022-06-08 00:50 EST | News | BioCryst Orladeyo gets approval in Switzerland to prevent hereditary angioedema attacks | N/A | |
About BioCryst Pharmaceuticals, Inc (BCRX):
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor, for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and Mundesine, an oral purine nucleoside phosphorylase inhibitor for peripheral T-cell lymphoma. It is also developing ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema; BCX9930, an oral factor D inhibitor, which is in Phase I clinical trials for mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitors that is in Phase I clinical trials to treat fibrodysplasia ossificans progressiva; and Galidesivir, a RNA dependent-RNA polymerase inhibitor, which is in Phase I clinical trials to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. The company has collaborations and in-license relationships with U.S. Department of Health and Human Services; National Institute of Allergy and Infectious Diseases; Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; Mundipharma International Holdings Limited; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.
General
- Name BioCryst Pharmaceuticals, Inc
- Symbol BCRX
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 246
- Fiscal Year EndDecember
- IPO Date1994-03-03
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.biocryst.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 31.41
- Price/Book (Most Recent Quarter) 56.59
- Enterprise Value Revenue 103.35
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$1.05
- Next Year EPS Estimate -$0.73
- Next Quarter EPS Estimate -$0.28
- Operating Margin -981%
- Return on Assets -43%
- Return on Equity -1925%
- Revenue 17.81 million
- Earnings Per Share -$1.15
- Revenue Per Share $0.11
- Gross Profit -106828000
- Quarterly Earnings Growth -89.9%
View More
Highlights
- Market Capitalization 2.25 billion
- EBITDA -106253000
- PE Ratio -12.32
- PEG Ratio -0.28
- Analyst Target Price $13.78
- Book Value Per Share $0.19
View More
Share Statistics
- Shares Outstanding 177.52 million
- Shares Float 162.86 million
- % Held by Insiders 85%
- % Held by Institutions 73.95%
- Shares Short 28.92 million
- Shares Short Prior Month 28.86 million
- Short Ratio 3.27
- Short % of Float 18%
- Short % of Shares Outstanding 16%
View More
Technicals
- Beta 2.82
- 52 Week High $13.93
- 52 Week Low $1.78
- 50 Day Moving Average 11.07
- 200 Day Moving Average 6.8
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
BioCryst Pharmaceuticals, Inc (BCRX) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
BioCryst Pharmaceuticals, Inc (BCRX) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-25 | $N/A | -$0.34 | -$0.24 | -42.56% |
| 2020-09-30 | 2020-11-05 | $N/A | -$0.26 | -$0.26 | -1.13% |
| 2020-06-30 | 2020-08-06 | $N/A | -$0.24 | -$0.25 | 4.53% |
| 2020-03-31 | 2020-05-06 | $N/A | -$0.24 | -$0.24 | 0.62% |
| 2019-12-31 | 2020-03-05 | $39.73 million | -$0.02 | -$0.27 | 92.51% |
| 2019-09-30 | 2019-11-06 | $1.78 million | -$0.34 | -$0.31 | -8.11% |
| 2019-06-30 | 2019-08-06 | $1.45 million | -$0.34 | -$0.32 | -7.12% |
| 2019-03-31 | 2019-05-08 | $5.89 million | -$0.28 | -$0.28 | -1.82% |
| 2018-12-31 | 2019-03-04 | $2.73 million | -$0.25 | -$0.24 | -2.75% |
| 2018-09-30 | 2018-11-06 | $1.45 million | -$0.28 | -$0.26 | -7.94% |
| 2018-06-30 | 2018-08-07 | $12.49 million | -$0.19 | -$0.24 | 21.26% |
| 2018-03-31 | 2018-05-08 | $3.98 million | -$0.26 | -$0.19 | -35.06% |
| 2017-12-31 | 2018-02-27 | $3.89 million | -$0.20 | -$0.16 | -26.5% |
| 2017-09-30 | 2017-11-07 | $8.76 million | -$0.18 | -$0.18 | 2.39% |
| 2017-06-30 | 2017-08-07 | $3.1 million | -$0.21 | -$0.19 | -10.53% |
| 2017-03-31 | 2017-05-04 | $9.44 million | -$0.19 | -$0.19 | -2.15% |
| 2016-12-31 | 2017-02-27 | $8.98 million | -$0.06 | -$0.24 | 74.82% |
| 2016-09-30 | 2016-11-07 | $7.76 million | -$0.16 | -$0.26 | 37.84% |
| 2016-06-30 | 2016-08-04 | $4.79 million | -$0.22 | -$0.26 | 15.25% |
| 2016-03-31 | 2016-05-05 | $4.82 million | -$0.31 | -$0.23 | -34.32% |
| 2015-12-31 | 2016-02-23 | $4.6 million | -$0.25 | -$0.25 | 0.68% |
| 2015-09-30 | 2015-11-05 | $10.99 million | -$0.20 | -$0.20 | 0% |
| 2015-06-30 | 2015-08-07 | $25.84 million | $0.06 | -$0.22 | 127.27% |
| 2015-03-31 | 2015-05-08 | $6.83 million | -$0.21 | -$0.25 | 16% |
| 2014-12-31 | 2015-02-18 | $5.45 million | -$0.16 | -$0.21 | 23.81% |
| 2014-09-30 | 2014-11-06 | $3.24 million | -$0.12 | -$0.20 | 40% |
| 2014-06-30 | 2014-08-05 | $1.47 million | -$0.23 | -$0.19 | -21.05% |
| 2014-03-31 | 2014-05-08 | $3.46 million | -$0.17 | -$0.17 | 0% |
| 2013-12-31 | 2014-02-26 | $10.57 million | -$0.09 | -$0.09 | 0% |
| 2013-09-30 | 2013-11-05 | $2.39 million | -$0.14 | -$0.11 | -27.27% |
| 2013-06-30 | 2013-08-08 | $821000 | -$0.23 | -$0.13 | -76.92% |
| 2013-03-31 | 2013-05-07 | $3.55 million | -$0.09 | -$0.15 | 40% |
| 2012-12-31 | 2013-02-19 | $4.1 million | -$0.18 | -$0.16 | -12.5% |
| 2012-09-30 | 2012-11-08 | $5.76 million | -$0.19 | -$0.25 | 24% |
| 2012-06-30 | 2012-08-02 | $4.21 million | -$0.25 | -$0.26 | 3.85% |
| 2012-03-31 | 2012-05-07 | $12.22 million | -$0.13 | -$0.26 | 50% |
| 2011-12-31 | 2012-02-16 | $5.22 million | -$0.29 | -$0.28 | -3.57% |
| 2011-09-30 | 2011-11-02 | $5.25 million | -$0.32 | -$0.26 | -23.08% |
| 2011-06-30 | 2011-08-04 | $3.74 million | -$0.36 | -$0.25 | -44% |
| 2011-03-31 | 2011-05-04 | $5.44 million | -$0.29 | -$0.20 | -45% |
| 2010-12-31 | 2011-02-10 | $16.69 million | -$0.20 | -$0.21 | 4.76% |
| 2010-09-30 | 2010-10-28 | $12 million | -$0.24 | -$0.17 | -41.18% |
| 2010-06-30 | 2010-08-05 | $7.62 million | -$0.23 | -$0.22 | -4.55% |
| 2010-03-31 | 2010-04-28 | $26.07 million | -$0.06 | -$0.16 | 62.5% |
| 2009-12-31 | 2010-02-04 | $54.9 million | $0.35 | $0.09 | 288.89% |
| 2009-09-30 | 2009-10-29 | $10.55 million | -$0.28 | -$0.22 | -27.27% |
| 2009-06-30 | 2009-07-30 | $4.79 million | -$0.23 | -$0.25 | 8% |
| 2009-03-31 | 2009-05-08 | $4.36 million | -$0.24 | -$0.28 | 14.29% |
| 2008-12-31 | 2009-02-06 | $34.24 million | $0.26 | -$0.22 | 218.18% |
| 2008-09-30 | 2008-10-31 | $8.89 million | -$0.24 | -$0.24 | 0% |
| 2008-06-30 | 2008-08-07 | $2.66 million | -$0.33 | -$0.20 | -65% |
| 2008-03-31 | 2008-05-08 | $10.77 million | -$0.34 | -$0.18 | -88.89% |
| 2007-12-31 | 2008-03-04 | $28.17 million | -$0.06 | -$0.39 | 84.62% |
| 2007-09-30 | 2007-11-08 | $20.46 million | -$0.32 | -$0.28 | -14.29% |
| 2007-06-30 | 2007-08-09 | $13.44 million | -$0.24 | -$0.33 | 27.27% |
| 2007-03-31 | 2007-05-09 | $9.16 million | -$0.30 | -$0.27 | -11.11% |
| 2006-12-31 | 2007-02-07 | $2.09 million | -$0.34 | -$0.50 | 32% |
| 2006-09-30 | 2006-11-08 | $1.79 million | -$0.53 | -$0.41 | -29.27% |
| 2006-06-30 | 2006-08-09 | $1.56 million | -$0.35 | -$0.29 | -20.69% |
| 2006-03-31 | 2006-04-27 | $771000 | -$0.27 | -$0.24 | -12.5% |
| 2005-12-31 | 2006-02-08 | $21000 | -$0.27 | -$0.29 | 6.9% |
| 2005-09-30 | 2005-10-26 | $32000 | -$0.29 | -$0.24 | -20.83% |
| 2005-06-30 | 2005-08-03 | $58000 | -$0.22 | -$0.25 | 12% |
| 2005-03-31 | 2005-04-21 | $41000 | -$0.24 | -$0.24 | 0% |
| 2004-12-31 | 2005-02-02 | $178000 | -$0.24 | -$0.26 | 7.69% |
| 2004-09-30 | 2004-10-20 | $116000 | -$0.24 | -$0.24 | 0% |
| 2004-06-30 | 2004-07-21 | $43000 | -$0.23 | -$0.28 | 17.86% |
| 2004-03-31 | 2004-04-21 | $N/A | -$0.28 | -$0.22 | -27.27% |
| 2003-12-31 | 2004-02-04 | $654000 | -$0.18 | -$0.20 | 10% |
| 2003-09-30 | 2003-10-20 | $N/A | -$0.19 | ||
| 2003-06-30 | 2003-07-30 | $N/A | -$0.18 | ||
| 2003-03-31 | 2003-03-31 | $N/A | -$0.16 | ||
| 2002-12-31 | 2002-12-31 | $N/A | -$0.16 | ||
| 2002-09-30 | 2002-09-30 | $N/A | -$0.19 | ||
| 2002-06-30 | 2002-06-30 | $N/A | -$0.29 | ||
| 2002-03-31 | 2002-03-31 | $N/A | -$0.32 | ||
| 2001-12-31 | 2002-01-30 | $4.34 million | -$0.28 | -$0.14 | -100% |
| 2001-09-30 | 2001-10-24 | $3.4 million | $0.02 | -$0.13 | 115.38% |
| 2001-06-30 | 2001-07-25 | $3.64 million | -$0.08 | -$0.12 | 33.33% |
| 2001-03-31 | 2001-04-25 | $703000 | -$0.08 | -$0.11 | 27.27% |
| 2000-12-31 | 2001-02-01 | $803000 | -$0.11 | -$0.12 | 8.33% |
| 2000-09-30 | 2000-10-25 | $763000 | -$0.09 | -$0.11 | 18.18% |
| 2000-06-30 | 2000-07-26 | $1.19 million | -$0.11 | -$0.12 | 8.33% |
| 2000-03-31 | 2000-04-26 | $564000 | $0.10 | -$0.04 | 350% |
| 1999-12-31 | 2000-02-02 | -$0.03 | -$0.01 | -200% | |
| 1999-09-30 | 1999-10-21 | -$0.15 | -$0.18 | 16.67% | |
| 1999-06-30 | 1999-07-21 | -$0.02 | -$0.08 | 75% | |
| 1999-03-31 | 1999-03-31 | -$0.16 | |||
| 1998-12-31 | 1999-01-27 | -$0.10 | -$0.24 | 58.33% | |
| 1998-09-30 | 1998-10-28 | $0.19 | $0.18 | 5.56% | |
| 1998-06-30 | 1998-07-22 | -$0.21 | -$0.25 | 16% | |
| 1998-03-31 | 1998-03-31 | -$0.22 | |||
| 1997-12-31 | 1998-02-03 | -$0.21 | -$0.23 | 8.7% | |
| 1997-03-31 | 1997-04-28 | -$0.23 | -$0.12 | -91.67% | |
| 1996-12-31 | 1997-02-10 | -$0.15 | -$0.21 | 28.57% | |
| 1996-09-30 | 1996-10-29 | -$0.23 | -$0.28 | 17.86% | |
| 1996-06-30 | 1996-07-25 | -$0.11 | $0.05 | -320% | |
| 1996-03-31 | 1996-04-24 | -$0.20 | -$0.26 | 23.08% | |
| 1995-12-31 | 1996-01-29 | -$0.23 | -$0.26 | 11.54% | |
| 1995-09-30 | 1995-10-17 | -$0.20 | -$0.23 | 13.04% | |
| 1995-06-30 | 1995-07-25 | -$0.18 | -$0.33 | 45.45% | |
| 1995-03-31 | 1995-04-28 | -$0.37 | -$0.31 | -19.35% | |
| 1994-12-31 | 1995-01-31 | -$0.24 | -$0.26 | 7.69% | |
| 1994-09-30 | 1994-10-26 | -$0.22 | -$0.31 | 29.03% | |
| 1994-06-30 | 1994-08-02 | -$0.25 | -$0.33 | 24.24% |
BioCryst Pharmaceuticals, Inc (BCRX) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
BioCryst Pharmaceuticals, Inc (BCRX) Chart:
BioCryst Pharmaceuticals, Inc (BCRX) News:
Below you will find a list of latest news for BioCryst Pharmaceuticals, Inc (BCRX) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
BioCryst Pharmaceuticals, Inc (BCRX) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-17 | 7.5 | 4.9 | CALL | 1 | 180 | 0.06 | TRUE | 0 | 0 |
| 2026-04-17 | 12.5 | 1.3 | CALL | 48 | 221 | 0.25 | FALSE | 0 | 0 |
| 2026-04-17 | 15 | 0 | CALL | 0 | 0 | 241.71 | FALSE | 0 | 0 |
| 2026-07-17 | 7.5 | 6.5 | CALL | 1 | 0.03 | TRUE | 0 | 0 | |
| 2026-07-17 | 12.5 | 0.85 | CALL | 2 | 18 | 0.25 | FALSE | 0 | 0 |
| 2026-07-17 | 10 | 0.15 | PUT | 102 | 0 | TRUE | 0 | 0 | |
| 2026-03-20 | 1 | 5.71 | CALL | 0 | 10 | 0 | TRUE | 0 | 0 |
| 2026-03-20 | 2 | 6.8 | CALL | 0 | 20 | 0 | TRUE | 0 | 0 |
| 2026-03-20 | 3 | 0 | CALL | 0 | 0 | 367.04 | TRUE | 0 | 0 |
| 2026-03-20 | 4 | 4.8 | CALL | 0 | 52 | 239.78 | TRUE | 0 | 0 |
| 2026-03-20 | 5 | 3.6 | CALL | 0 | 193 | 0 | TRUE | 0 | 0 |
| 2026-03-20 | 6 | 2.65 | CALL | 0 | 45 | 0 | TRUE | 0 | 0 |
| 2026-03-20 | 7 | 1.85 | CALL | 15 | 3061 | 117.23 | TRUE | 0.4 | 0.28 |
| 2026-03-20 | 8 | 0.8 | CALL | 245 | 5029 | 47.99 | TRUE | 0.1 | 0.14 |
| 2026-03-20 | 9 | 0.21 | CALL | 1290 | 1174 | 53.97 | FALSE | 0.02 | 0.11 |
| 2026-03-20 | 10 | 0.05 | CALL | 5438 | 7405 | 64.02 | FALSE | 0 | 0 |
| 2026-03-20 | 11 | 0.02 | CALL | 0 | 682 | 253.16 | FALSE | 0 | 0 |
| 2026-03-20 | 12 | 0.05 | CALL | 0 | 234 | 120.62 | FALSE | 0 | 0 |
| 2026-03-20 | 13 | 0.05 | CALL | 0 | 23 | 283.63 | FALSE | 0 | 0 |
| 2026-03-20 | 14 | 0 | CALL | 0 | 0 | 842.37 | FALSE | 0 | 0 |
| 2026-03-20 | 15 | 0.05 | CALL | 0 | 47 | 181.59 | FALSE | 0 | 0 |
| 2026-03-20 | 16 | 0 | CALL | 0 | 0 | 523.51 | FALSE | 0 | 0 |
| 2026-03-20 | 17 | 0.05 | CALL | 0 | 142 | 242.99 | FALSE | 0 | 0 |
| 2026-03-20 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-03-20 | 2 | 0 | PUT | 0 | 0 | 581.15 | FALSE | 0 | 0 |
| 2026-03-20 | 3 | 0.26 | PUT | 0 | 25 | 771.49 | FALSE | 0 | 0 |
| 2026-03-20 | 4 | 0 | PUT | 0 | 0 | 1122.43 | FALSE | 0 | 0 |
| 2026-03-20 | 5 | 0.08 | PUT | 0 | 241 | 357.37 | FALSE | 0 | 0 |
| 2026-03-20 | 6 | 0.04 | PUT | 0 | 678 | 200.08 | FALSE | 0 | 0 |
| 2026-03-20 | 7 | 0.06 | PUT | 0 | 1690 | 136.82 | FALSE | 0 | 0 |
| 2026-03-20 | 8 | 0.15 | PUT | 0 | 497 | 71.16 | FALSE | 0 | 0 |
| 2026-03-20 | 9 | 0.69 | PUT | 0 | 457 | 30.38 | TRUE | 0 | 0 |
| 2026-03-20 | 10 | 1.57 | PUT | 0 | 187 | 244.12 | TRUE | 0 | 0 |
| 2026-03-20 | 11 | 0 | PUT | 0 | 0 | 202.96 | TRUE | 0 | 0 |
| 2026-03-20 | 12 | 0 | PUT | 0 | 0 | 175.55 | TRUE | 0 | 0 |
| 2026-03-20 | 13 | 0 | PUT | 0 | 0 | 216.98 | TRUE | 0 | 0 |
| 2026-03-20 | 14 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-03-20 | 15 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-03-20 | 16 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-03-20 | 17 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-04-17 | 1 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-04-17 | 2 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-04-17 | 3 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-04-17 | 4 | 0 | CALL | 0 | 0 | 109.6 | TRUE | 0 | 0 |
| 2026-04-17 | 5 | 0 | CALL | 0 | 0 | 216.86 | TRUE | 0 | 0 |
| 2026-04-17 | 6 | 0 | CALL | 0 | 0 | 118.07 | TRUE | 0 | 0 |
| 2026-04-17 | 7 | 1.1 | CALL | 0 | 10 | 66.21 | TRUE | 0 | 0 |
| 2026-04-17 | 8 | 1.1 | CALL | 1 | 36 | 59.09 | TRUE | 0.2 | 0.22 |
| 2026-04-17 | 9 | 0.53 | CALL | 75 | 468 | 55.48 | FALSE | 0.08 | 0.18 |
| 2026-04-17 | 10 | 0.2 | CALL | 710 | 201 | 52.32 | FALSE | 0.05 | 0.33 |
| 2026-04-17 | 11 | 0.5 | CALL | 0 | 1 | 78.1 | FALSE | 0 | 0 |
| 2026-04-17 | 12 | 0 | CALL | 0 | 0 | 107.1 | FALSE | 0 | 0 |
| 2026-04-17 | 13 | 0 | CALL | 0 | 0 | 184.76 | FALSE | 0 | 0 |
| 2026-04-17 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-04-17 | 2 | 0 | PUT | 0 | 0 | 663.8 | FALSE | 0 | 0 |
| 2026-04-17 | 3 | 0 | PUT | 0 | 0 | 527.51 | FALSE | 0 | 0 |
| 2026-04-17 | 4 | 0 | PUT | 0 | 0 | 364.26 | FALSE | 0 | 0 |
| 2026-04-17 | 5 | 0 | PUT | 0 | 0 | 347.81 | FALSE | 0 | 0 |
| 2026-04-17 | 6 | 0 | PUT | 0 | 0 | 275.05 | FALSE | 0 | 0 |
| 2026-04-17 | 7 | 0.24 | PUT | 0 | 30 | 117.92 | FALSE | 0 | 0 |
| 2026-04-17 | 8 | 0.85 | PUT | 0 | 2 | 116.97 | FALSE | 0 | 0 |
| 2026-04-17 | 9 | 0.72 | PUT | 0 | 10 | 447.06 | TRUE | 0 | 0 |
| 2026-04-17 | 10 | 0 | PUT | 0 | 8 | 366.32 | TRUE | 0 | 0 |
| 2026-04-17 | 11 | 0 | PUT | 0 | 0 | 82.1 | TRUE | 0 | 0 |
| 2026-04-17 | 12 | 0 | PUT | 0 | 0 | 105.55 | TRUE | 0 | 0 |
| 2026-04-17 | 13 | 0 | PUT | 0 | 0 | 120.91 | TRUE | 0 | 0 |
| 2026-04-17 | 15 | 0 | PUT | 0 | 0 | 146.64 | TRUE | 0 | 0 |
| 2026-06-18 | 1 | 5.6 | CALL | 0 | 1 | 0 | TRUE | 0 | 0 |
| 2026-06-18 | 2 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-06-18 | 3 | 0 | CALL | 0 | 0 | 126.48 | TRUE | 0 | 0 |
| 2026-06-18 | 4 | 4.9 | CALL | 0 | 4 | 0 | TRUE | 0 | 0 |
| 2026-06-18 | 5 | 3.5 | CALL | 0 | 75 | 91.12 | TRUE | 0 | 0 |
| 2026-06-18 | 6 | 3.4 | CALL | 0 | 12 | 0 | TRUE | 0 | 0 |
| 2026-06-18 | 7 | 2.12 | CALL | 16 | 956 | 58.1 | TRUE | 2.12 | 0 |
| 2026-06-18 | 8 | 1.4 | CALL | 118 | 773 | 53.43 | TRUE | 0.19 | 0.16 |
| 2026-06-18 | 9 | 0.9 | CALL | 58 | 222 | 53.2 | FALSE | 0.13 | 0.17 |
| 2026-06-18 | 10 | 0.57 | CALL | 629 | 524 | 53.96 | FALSE | 0.57 | 0 |
| 2026-06-18 | 11 | 0.23 | CALL | 0 | 69 | 66.95 | FALSE | 0 | 0 |
| 2026-06-18 | 12 | 0.4 | CALL | 0 | 1 | 65.27 | FALSE | 0 | 0 |
| 2026-06-18 | 13 | 0.09 | CALL | 0 | 5 | 177.04 | FALSE | 0 | 0 |
| 2026-06-18 | 15 | 0 | CALL | 0 | 0 | 130.72 | FALSE | 0 | 0 |
| 2026-06-18 | 1 | 0 | PUT | 0 | 0 | 236.66 | FALSE | 0 | 0 |
| 2026-06-18 | 2 | 0 | PUT | 0 | 0 | 424.12 | FALSE | 0 | 0 |
| 2026-06-18 | 3 | 0 | PUT | 0 | 0 | 335.02 | FALSE | 0 | 0 |
| 2026-06-18 | 4 | 0 | PUT | 0 | 0 | 600.64 | FALSE | 0 | 0 |
| 2026-06-18 | 5 | 0 | PUT | 0 | 0 | 853.12 | FALSE | 0 | 0 |
| 2026-06-18 | 6 | 0.35 | PUT | 0 | 30 | 166.85 | FALSE | 0 | 0 |
| 2026-06-18 | 7 | 0.39 | PUT | 0 | 512 | 109.39 | FALSE | 0 | 0 |
| 2026-06-18 | 8 | 2.8 | PUT | 0 | 32 | 337.97 | FALSE | 0 | 0 |
| 2026-06-18 | 9 | 1.1 | PUT | 0 | 105 | 53.59 | TRUE | 0 | 0 |
| 2026-06-18 | 10 | 0 | PUT | 0 | 0 | 53.39 | TRUE | 0 | 0 |
| 2026-06-18 | 11 | 0 | PUT | 0 | 0 | 60.01 | TRUE | 0 | 0 |
| 2026-06-18 | 12 | 0 | PUT | 0 | 0 | 64.47 | TRUE | 0 | 0 |
| 2026-06-18 | 13 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-06-18 | 15 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-09-18 | 1 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-09-18 | 2 | 0 | CALL | 0 | 0 | 121.2 | TRUE | 0 | 0 |
| 2026-09-18 | 3 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-09-18 | 4 | 5 | CALL | 5 | 10 | 87.1 | TRUE | 5 | 0 |
| 2026-09-18 | 5 | 0 | CALL | 0 | 0 | 92.35 | TRUE | 0 | 0 |
| 2026-09-18 | 6 | 0 | CALL | 0 | 0 | 72.76 | TRUE | 0 | 0 |
| 2026-09-18 | 7 | 1.2 | CALL | 0 | 55 | 67.33 | TRUE | 0 | 0 |
| 2026-09-18 | 8 | 1.27 | CALL | 0 | 7 | 37.76 | TRUE | 0 | 0 |
| 2026-09-18 | 9 | 1.45 | CALL | 1 | 157 | 59 | FALSE | 1.45 | 0 |
| 2026-09-18 | 10 | 1.05 | CALL | 2 | 86 | 57.13 | FALSE | 1.05 | 0 |
| 2026-09-18 | 11 | 0.75 | CALL | 14 | 17 | 55.87 | FALSE | 0.75 | 0 |
| 2026-09-18 | 12 | 0.5 | CALL | 13 | 8 | 53.58 | FALSE | 0 | 0 |
| 2026-09-18 | 13 | 0.43 | CALL | 0 | 3 | 54.47 | FALSE | 0 | 0 |
| 2026-09-18 | 14 | 0 | CALL | 0 | 0 | 78.8 | FALSE | 0 | 0 |
| 2026-09-18 | 15 | 0 | CALL | 0 | 0 | 93.55 | FALSE | 0 | 0 |
| 2026-09-18 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-09-18 | 2 | 0 | PUT | 0 | 0 | 478.91 | FALSE | 0 | 0 |
| 2026-09-18 | 3 | 0 | PUT | 0 | 0 | 281.21 | FALSE | 0 | 0 |
| 2026-09-18 | 4 | 0 | PUT | 0 | 0 | 164.25 | FALSE | 0 | 0 |
| 2026-09-18 | 5 | 0 | PUT | 0 | 0 | 129 | FALSE | 0 | 0 |
| 2026-09-18 | 6 | 0.35 | PUT | 0 | 23 | 115.92 | FALSE | 0 | 0 |
| 2026-09-18 | 7 | 0.9 | PUT | 0 | 1 | 115.39 | FALSE | 0 | 0 |
| 2026-09-18 | 8 | 1.6 | PUT | 0 | 9 | 205.91 | FALSE | 0 | 0 |
| 2026-09-18 | 9 | 1.45 | PUT | 0 | 41 | 62.19 | TRUE | 0 | 0 |
| 2026-09-18 | 10 | 0 | PUT | 0 | 0 | 58.67 | TRUE | 0 | 0 |
| 2026-09-18 | 11 | 0 | PUT | 0 | 0 | 56.67 | TRUE | 0 | 0 |
| 2026-09-18 | 12 | 0 | PUT | 0 | 0 | 54.49 | TRUE | 0 | 0 |
| 2026-09-18 | 13 | 0 | PUT | 0 | 0 | 56.77 | TRUE | 0 | 0 |
| 2026-09-18 | 14 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-09-18 | 15 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2027-01-15 | 3 | 5.8 | CALL | 0 | 198 | 152.06 | TRUE | 0 | 0 |
| 2027-01-15 | 5 | 4.05 | CALL | 0 | 1361 | 0 | TRUE | 0 | 0 |
| 2027-01-15 | 7 | 2.8 | CALL | 31 | 3917 | 58.08 | TRUE | 0.2 | 0.08 |
| 2027-01-15 | 10 | 1.35 | CALL | 6 | 8549 | 53.05 | FALSE | 1.35 | 0 |
| 2027-01-15 | 12 | 0.77 | CALL | 14 | 878 | 50.56 | FALSE | 0.77 | 0 |
| 2027-01-15 | 15 | 0.4 | CALL | 0 | 1045 | 49.96 | FALSE | 0 | 0 |
| 2027-01-15 | 17 | 0.35 | CALL | 0 | 43 | 61.84 | FALSE | 0 | 0 |
| 2027-01-15 | 20 | 0.2 | CALL | 30 | 633 | 57.62 | FALSE | 0 | 0 |
| 2027-01-15 | 3 | 0.13 | PUT | 0 | 13 | 111.58 | FALSE | 0 | 0 |
| 2027-01-15 | 5 | 0.34 | PUT | 0 | 128 | 74.67 | FALSE | 0 | 0 |
| 2027-01-15 | 7 | 0.8 | PUT | 0 | 181 | 59.23 | FALSE | 0 | 0 |
| 2027-01-15 | 10 | 2.42 | PUT | 0 | 908 | 51.85 | TRUE | 0 | 0 |
| 2027-01-15 | 12 | 2.5 | PUT | 0 | 11 | 81.54 | TRUE | 0 | 0 |
| 2027-01-15 | 15 | 0 | PUT | 0 | 1 | 57.84 | TRUE | 0 | 0 |
| 2027-01-15 | 17 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2027-01-15 | 20 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
Latest BCRX Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 62 | $9.355 |
| Jun 13, 2022 7:59 PM EST | 55 | $9.355 |
| Jun 13, 2022 7:59 PM EST | 25 | $9.355 |
| Jun 13, 2022 7:59 PM EST | 10 | $9.355 |
| Jun 13, 2022 7:59 PM EST | 1 | $9.355 |
BioCryst Pharmaceuticals, Inc (BCRX) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882796/000110465920072065/0001104659-20-072065-index.htm |
| 2020-04-27 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/882796/000000000020003589/0000000000-20-003589-index.htm |
| 2019-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882796/000021545719003209/0000215457-19-003209-index.htm |
| 2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882796/000083423720004615/0000834237-20-004615-index.htm |
| 2019-11-19 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882796/000089914019000618/0000899140-19-000618-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882796/000089914020000183/0000899140-20-000183-index.htm |
| 2020-04-17 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882796/000090266420001843/0000902664-20-001843-index.htm |
| 2019-01-11 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882796/000093041319000073/0000930413-19-000073-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882796/000093247119004892/0000932471-19-004892-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882796/000110465919008702/0001104659-19-008702-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882796/000110465920018856/0001104659-20-018856-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882796/000110465920021757/0001104659-20-021757-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882796/000110465920021905/0001104659-20-021905-index.htm |
| 2020-06-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882796/000110465920072065/0001104659-20-072065-index.htm |
| 2018-12-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760218036067/0001127602-18-036067-index.htm |
| 2018-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760218036977/0001127602-18-036977-index.htm |
| 2018-12-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760218037163/0001127602-18-037163-index.htm |
| 2018-12-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760218037166/0001127602-18-037166-index.htm |
| 2018-12-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760218037170/0001127602-18-037170-index.htm |
| 2018-12-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760218037173/0001127602-18-037173-index.htm |
| 2018-12-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760218037177/0001127602-18-037177-index.htm |
| 2018-12-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760218037182/0001127602-18-037182-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219000701/0001127602-19-000701-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219000710/0001127602-19-000710-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219000720/0001127602-19-000720-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219000730/0001127602-19-000730-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219000736/0001127602-19-000736-index.htm |
| 2019-01-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219001579/0001127602-19-001579-index.htm |
| 2019-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219001582/0001127602-19-001582-index.htm |
| 2019-01-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219002141/0001127602-19-002141-index.htm |
| 2019-01-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219002367/0001127602-19-002367-index.htm |
| 2019-01-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219002527/0001127602-19-002527-index.htm |
| 2019-01-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm |
| 2019-01-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219003053/0001127602-19-003053-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219003737/0001127602-19-003737-index.htm |
| 2019-03-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219011361/0001127602-19-011361-index.htm |
| 2019-04-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219014988/0001127602-19-014988-index.htm |
| 2019-05-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219017457/0001127602-19-017457-index.htm |
| 2019-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219018347/0001127602-19-018347-index.htm |
| 2019-05-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219018740/0001127602-19-018740-index.htm |
| 2019-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219019143/0001127602-19-019143-index.htm |
| 2019-05-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219019891/0001127602-19-019891-index.htm |
| 2019-05-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219020298/0001127602-19-020298-index.htm |
| 2019-05-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219020302/0001127602-19-020302-index.htm |
| 2019-05-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219020306/0001127602-19-020306-index.htm |
| 2019-05-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219020310/0001127602-19-020310-index.htm |
| 2019-05-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219020312/0001127602-19-020312-index.htm |
| 2019-05-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219020314/0001127602-19-020314-index.htm |
| 2019-07-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219023817/0001127602-19-023817-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219023901/0001127602-19-023901-index.htm |
| 2019-09-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219027858/0001127602-19-027858-index.htm |
| 2019-09-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219027862/0001127602-19-027862-index.htm |
| 2019-09-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219027867/0001127602-19-027867-index.htm |
| 2019-09-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219027871/0001127602-19-027871-index.htm |
| 2019-09-24 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219029010/0001127602-19-029010-index.htm |
| 2019-09-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219029012/0001127602-19-029012-index.htm |
| 2019-11-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219033001/0001127602-19-033001-index.htm |
| 2019-11-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219033004/0001127602-19-033004-index.htm |
| 2019-11-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219033008/0001127602-19-033008-index.htm |
| 2019-11-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219033017/0001127602-19-033017-index.htm |
| 2019-11-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219033022/0001127602-19-033022-index.htm |
| 2019-11-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219033025/0001127602-19-033025-index.htm |
| 2019-11-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219033029/0001127602-19-033029-index.htm |
| 2019-11-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219033033/0001127602-19-033033-index.htm |
| 2019-11-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219033035/0001127602-19-033035-index.htm |
| 2019-12-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219034162/0001127602-19-034162-index.htm |
| 2019-12-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219034165/0001127602-19-034165-index.htm |
| 2019-12-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219034168/0001127602-19-034168-index.htm |
| 2019-12-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219034170/0001127602-19-034170-index.htm |
| 2019-12-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219035542/0001127602-19-035542-index.htm |
| 2019-12-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219035544/0001127602-19-035544-index.htm |
| 2019-12-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219035547/0001127602-19-035547-index.htm |
| 2019-12-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219035549/0001127602-19-035549-index.htm |
| 2019-12-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219035551/0001127602-19-035551-index.htm |
| 2019-12-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219035553/0001127602-19-035553-index.htm |
| 2019-12-26 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219035849/0001127602-19-035849-index.htm |
| 2019-12-26 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760219035852/0001127602-19-035852-index.htm |
| 2020-01-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220001879/0001127602-20-001879-index.htm |
| 2020-01-21 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220001981/0001127602-20-001981-index.htm |
| 2020-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220006477/0001127602-20-006477-index.htm |
| 2020-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220006488/0001127602-20-006488-index.htm |
| 2020-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220006497/0001127602-20-006497-index.htm |
| 2020-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220006501/0001127602-20-006501-index.htm |
| 2020-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220006505/0001127602-20-006505-index.htm |
| 2020-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220006508/0001127602-20-006508-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220007615/0001127602-20-007615-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220007625/0001127602-20-007625-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220007640/0001127602-20-007640-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220007672/0001127602-20-007672-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220007677/0001127602-20-007677-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220007687/0001127602-20-007687-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220009058/0001127602-20-009058-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220009065/0001127602-20-009065-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220009089/0001127602-20-009089-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220009094/0001127602-20-009094-index.htm |
| 2020-03-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220009104/0001127602-20-009104-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220009112/0001127602-20-009112-index.htm |
| 2020-04-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220013457/0001127602-20-013457-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220015179/0001127602-20-015179-index.htm |
| 2020-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220016548/0001127602-20-016548-index.htm |
| 2020-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220016559/0001127602-20-016559-index.htm |
| 2020-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220016565/0001127602-20-016565-index.htm |
| 2020-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220016569/0001127602-20-016569-index.htm |
| 2020-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220016571/0001127602-20-016571-index.htm |
| 2020-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220016575/0001127602-20-016575-index.htm |
| 2020-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220016580/0001127602-20-016580-index.htm |
| 2020-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220016584/0001127602-20-016584-index.htm |
| 2020-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220016759/0001127602-20-016759-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220018704/0001127602-20-018704-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220018711/0001127602-20-018711-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220018715/0001127602-20-018715-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220018719/0001127602-20-018719-index.htm |
| 2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220023449/0001127602-20-023449-index.htm |
| 2020-09-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220024637/0001127602-20-024637-index.htm |
| 2020-09-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220024642/0001127602-20-024642-index.htm |
| 2020-09-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220024644/0001127602-20-024644-index.htm |
| 2020-09-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/882796/000112760220024646/0001127602-20-024646-index.htm |
| 2019-11-12 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/882796/000114036119020338/0001140361-19-020338-index.htm |
| 2019-11-14 | 424B2 | Prospectus [Rule 424(b)(2)] | https://www.sec.gov/Archives/edgar/data/882796/000114036119020642/0001140361-19-020642-index.htm |
| 2019-11-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000114036119020752/0001140361-19-020752-index.htm |
| 2019-11-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000114036119020989/0001140361-19-020989-index.htm |
| 2019-11-21 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/882796/000114036119021082/0001140361-19-021082-index.htm |
| 2019-11-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000114036119021088/0001140361-19-021088-index.htm |
| 2020-04-24 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/882796/000114036120009639/0001140361-20-009639-index.htm |
| 2020-05-04 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/882796/000114036120010641/0001140361-20-010641-index.htm |
| 2020-05-12 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/882796/000114036120011394/0001140361-20-011394-index.htm |
| 2020-05-27 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/882796/000114036120012557/0001140361-20-012557-index.htm |
| 2020-05-29 | 424B2 | Prospectus [Rule 424(b)(2)] | https://www.sec.gov/Archives/edgar/data/882796/000114036120012652/0001140361-20-012652-index.htm |
| 2020-06-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000114036120012787/0001140361-20-012787-index.htm |
| 2020-06-10 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/882796/000114036120013520/0001140361-20-013520-index.htm |
| 2020-06-10 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/882796/000114036120013521/0001140361-20-013521-index.htm |
| 2020-06-10 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/882796/000114036120013522/0001140361-20-013522-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882796/000114420419007217/0001144204-19-007217-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882796/000114420419008282/0001144204-19-008282-index.htm |
| 2019-01-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184319000006/0001171843-19-000006-index.htm |
| 2019-01-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184319000126/0001171843-19-000126-index.htm |
| 2019-02-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184319000749/0001171843-19-000749-index.htm |
| 2019-02-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184319001171/0001171843-19-001171-index.htm |
| 2019-03-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184319001442/0001171843-19-001442-index.htm |
| 2019-03-14 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/882796/000117184319001727/0001171843-19-001727-index.htm |
| 2019-04-17 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/882796/000117184319002458/0001171843-19-002458-index.htm |
| 2019-04-17 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/882796/000117184319002459/0001171843-19-002459-index.htm |
| 2019-04-29 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/882796/000117184319002720/0001171843-19-002720-index.htm |
| 2019-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184319003094/0001171843-19-003094-index.htm |
| 2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/882796/000117184319003220/0001171843-19-003220-index.htm |
| 2019-05-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184319003529/0001171843-19-003529-index.htm |
| 2019-06-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184319003812/0001171843-19-003812-index.htm |
| 2019-06-04 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/882796/000117184319003816/0001171843-19-003816-index.htm |
| 2019-06-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184319004220/0001171843-19-004220-index.htm |
| 2019-07-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184319004257/0001171843-19-004257-index.htm |
| 2019-07-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184319004259/0001171843-19-004259-index.htm |
| 2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184319005182/0001171843-19-005182-index.htm |
| 2019-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/882796/000117184319005326/0001171843-19-005326-index.htm |
| 2019-09-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184319005941/0001171843-19-005941-index.htm |
| 2019-09-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184319006063/0001171843-19-006063-index.htm |
| 2019-09-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184319006137/0001171843-19-006137-index.htm |
| 2019-10-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184319006859/0001171843-19-006859-index.htm |
| 2019-11-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184319007064/0001171843-19-007064-index.htm |
| 2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184319007155/0001171843-19-007155-index.htm |
| 2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184319007214/0001171843-19-007214-index.htm |
| 2019-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184319007363/0001171843-19-007363-index.htm |
| 2019-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/882796/000117184319007384/0001171843-19-007384-index.htm |
| 2019-12-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184319008053/0001171843-19-008053-index.htm |
| 2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184320000183/0001171843-20-000183-index.htm |
| 2020-01-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184320000241/0001171843-20-000241-index.htm |
| 2020-02-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184320000650/0001171843-20-000650-index.htm |
| 2020-02-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184320001018/0001171843-20-001018-index.htm |
| 2020-02-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184320001229/0001171843-20-001229-index.htm |
| 2020-03-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184320001491/0001171843-20-001491-index.htm |
| 2020-03-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184320001492/0001171843-20-001492-index.htm |
| 2020-03-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184320001589/0001171843-20-001589-index.htm |
| 2020-03-13 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/882796/000117184320001710/0001171843-20-001710-index.htm |
| 2020-03-19 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/882796/000117184320001853/0001171843-20-001853-index.htm |
| 2020-03-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184320002124/0001171843-20-002124-index.htm |
| 2020-03-31 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/882796/000117184320002184/0001171843-20-002184-index.htm |
| 2020-03-31 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/882796/000117184320002185/0001171843-20-002185-index.htm |
| 2020-04-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184320002295/0001171843-20-002295-index.htm |
| 2020-04-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184320002530/0001171843-20-002530-index.htm |
| 2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184320003357/0001171843-20-003357-index.htm |
| 2020-05-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/882796/000117184320003557/0001171843-20-003557-index.htm |
| 2020-05-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184320003680/0001171843-20-003680-index.htm |
| 2020-08-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184320005453/0001171843-20-005453-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184320005596/0001171843-20-005596-index.htm |
| 2020-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/882796/000117184320005753/0001171843-20-005753-index.htm |
| 2020-08-12 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/882796/000117184320005862/0001171843-20-005862-index.htm |
| 2020-08-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184320006161/0001171843-20-006161-index.htm |
| 2020-08-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184320006178/0001171843-20-006178-index.htm |
| 2020-09-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184320006249/0001171843-20-006249-index.htm |
| 2020-09-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184320006729/0001171843-20-006729-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/882796/000117184320007628/0001171843-20-007628-index.htm |
| 2020-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/882796/000117184320007740/0001171843-20-007740-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882796/000117266120000839/0001172661-20-000839-index.htm |
| 2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882796/000119380519000192/0001193805-19-000192-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882796/000119380520000190/0001193805-20-000190-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882796/000127417319000036/0001274173-19-000036-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882796/000127417320000008/0001274173-20-000008-index.htm |
| 2019-05-29 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882796/000131924419000051/0001319244-19-000051-index.htm |
| 2020-01-22 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/882796/000131924420000014/0001319244-20-000014-index.htm |
| 2020-05-14 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/882796/999999999520001159/9999999995-20-001159-index.htm |
| 2018-12-17 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/882796/999999999718009595/9999999997-18-009595-index.htm |
| 2020-05-01 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/882796/999999999720002395/9999999997-20-002395-index.htm |
BioCryst Pharmaceuticals, Inc (BCRX) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of BioCryst Pharmaceuticals, Inc (BCRX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 85%Institutional Ownership: 7395%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2018-12-10 | Lynne Powell | Senior VP - CCO | Sell | 2,000.00 | 9.01 | 18,020.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760218036067/0001127602-18-036067-index.htm |
| 2018-12-10 | Lynne Powell | Senior VP - CCO | Sell | 2,000.00 | 9.11 | 18,220.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760218036067/0001127602-18-036067-index.htm |
| 2019-01-14 | Lynne Powell | Senior VP - CCO | Sell | 954.00 | 9.20 | 8,776.80 | 0.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219002141/0001127602-19-002141-index.htm |
| 2019-01-16 | Lynne Powell | Senior VP - CCO | Sell | 3,046.00 | 9.27 | 28,236.42 | 0.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219002367/0001127602-19-002367-index.htm |
| 2019-01-18 | Lynne Powell | Senior VP - CCO | Sell | 2,000.00 | 9.40 | 18,800.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219002527/0001127602-19-002527-index.htm |
| 2019-01-25 | Lynne Powell | Senior VP - CCO | Sell | 6,000.00 | 9.60 | 57,600.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm |
| 2019-01-28 | Lynne Powell | Senior VP - CCO | Sell | 4,000.00 | 9.88 | 39,520.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm |
| 2019-01-28 | Lynne Powell | Senior VP - CCO | Sell | 2,000.00 | 9.91 | 19,820.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm |
| 2020-03-01 | THERESA HEGGIE | Director | Buy | 1,666.00 | 3.00 | 4,998.00 | 10,092.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760220009089/0001127602-20-009089-index.htm |
| 2019-11-18 | Alane P Barnes | Senior VP, Chief Legal Officer | Buy | 20,000.00 | 1.45 | 29,000.00 | 102,061.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219033008/0001127602-19-033008-index.htm |
| 2020-06-01 | THERESA HEGGIE | Director | Buy | 1,112.00 | 4.50 | 4,998.44 | 11,204.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760220018715/0001127602-20-018715-index.htm |
| 2020-08-31 | THERESA HEGGIE | Director | Buy | 1,204.00 | 4.15 | 4,996.60 | 12,408.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760220024644/0001127602-20-024644-index.htm |
| 2019-05-17 | THOMAS R II STAAB | Senior Vice President and CFO | Sell | 2,500.00 | 7.45 | 18,625.00 | 125,176.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219019143/0001127602-19-019143-index.htm |
| 2019-05-16 | THOMAS R II STAAB | Senior Vice President and CFO | Sell | 7,250.00 | 7.72 | 55,970.00 | 127,676.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219019143/0001127602-19-019143-index.htm |
| 2019-01-31 | Yarlagadda S Babu | Senior VP - Drug Discovery | Buy | 19,686.00 | 1.20 | 23,623.20 | 127,786.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219003737/0001127602-19-003737-index.htm |
| 2019-01-28 | THOMAS R II STAAB | Senior Vice President and CFO | Sell | 5,000.00 | 9.85 | 49,250.00 | 128,426.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219003053/0001127602-19-003053-index.htm |
| 2019-05-15 | THOMAS R II STAAB | Senior Vice President and CFO | Sell | 7,250.00 | 7.92 | 57,420.00 | 130,176.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219018740/0001127602-19-018740-index.htm |
| 2019-01-31 | Yarlagadda S Babu | Senior VP - Drug Discovery | Buy | 12,188.00 | 1.20 | 14,625.60 | 132,272.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219003737/0001127602-19-003737-index.htm |
| 2019-04-04 | THOMAS R II STAAB | Senior Vice President and CFO | Sell | 7,500.00 | 8.81 | 66,075.00 | 132,676.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219014988/0001127602-19-014988-index.htm |
| 2019-05-02 | THOMAS R II STAAB | Senior Vice President and CFO | Sell | 7,750.00 | 7.30 | 56,575.00 | 132,676.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219017457/0001127602-19-017457-index.htm |
| 2019-05-06 | THOMAS R II STAAB | Senior Vice President and CFO | Sell | 9,000.00 | 7.75 | 69,750.00 | 132,676.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219017457/0001127602-19-017457-index.htm |
| 2019-05-09 | THOMAS R II STAAB | Senior Vice President and CFO | Sell | 9,750.00 | 7.63 | 74,392.50 | 132,676.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219018347/0001127602-19-018347-index.htm |
| 2019-05-13 | THOMAS R II STAAB | Senior Vice President and CFO | Sell | 9,750.00 | 7.76 | 75,660.00 | 132,676.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219018347/0001127602-19-018347-index.htm |
| 2019-05-14 | THOMAS R II STAAB | Senior Vice President and CFO | Sell | 4,500.00 | 7.62 | 34,290.00 | 132,676.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219018740/0001127602-19-018740-index.htm |
| 2019-01-28 | THOMAS R II STAAB | Senior Vice President and CFO | Buy | 5,000.00 | 5.45 | 27,250.00 | 133,426.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219003053/0001127602-19-003053-index.htm |
| 2019-05-16 | THOMAS R II STAAB | Senior Vice President and CFO | Buy | 4,750.00 | 1.42 | 6,745.00 | 134,926.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219019143/0001127602-19-019143-index.htm |
| 2019-05-14 | THOMAS R II STAAB | Senior Vice President and CFO | Buy | 4,500.00 | 1.42 | 6,390.00 | 137,176.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219018740/0001127602-19-018740-index.htm |
| 2019-05-15 | THOMAS R II STAAB | Senior Vice President and CFO | Buy | 4,750.00 | 1.42 | 6,745.00 | 137,426.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219018740/0001127602-19-018740-index.htm |
| 2019-04-04 | THOMAS R II STAAB | Senior Vice President and CFO | Buy | 7,500.00 | 5.51 | 41,325.00 | 140,176.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219014988/0001127602-19-014988-index.htm |
| 2019-05-02 | THOMAS R II STAAB | Senior Vice President and CFO | Buy | 7,750.00 | 5.51 | 42,702.50 | 140,426.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219017457/0001127602-19-017457-index.htm |
| 2019-05-06 | THOMAS R II STAAB | Senior Vice President and CFO | Buy | 9,000.00 | 5.51 | 49,590.00 | 141,676.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219017457/0001127602-19-017457-index.htm |
| 2019-05-09 | THOMAS R II STAAB | Senior Vice President and CFO | Buy | 9,750.00 | 5.51 | 53,722.50 | 142,426.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219018347/0001127602-19-018347-index.htm |
| 2019-05-13 | THOMAS R II STAAB | Senior Vice President and CFO | Buy | 9,750.00 | 5.51 | 53,722.50 | 142,426.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219018347/0001127602-19-018347-index.htm |
| 2019-11-18 | KENNETH B JR LEE | Director | Buy | 5,000.00 | 1.45 | 7,250.00 | 15,252.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219033029/0001127602-19-033029-index.htm |
| 2019-11-18 | Yarlagadda S Babu | Senior VP - Drug Discovery | Buy | 25,000.00 | 1.45 | 36,250.00 | 155,587.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219033004/0001127602-19-033004-index.htm |
| 2019-09-01 | THERESA HEGGIE | Director | Buy | 1,672.00 | 2.99 | 4,999.28 | 1,672.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219027871/0001127602-19-027871-index.htm |
| 2018-12-10 | Lynne Powell | Senior VP - CCO | Buy | 2,000.00 | 3.22 | 6,440.00 | 2,000.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760218036067/0001127602-18-036067-index.htm |
| 2019-01-18 | Lynne Powell | Senior VP - CCO | Buy | 2,000.00 | 3.22 | 6,440.00 | 2,000.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219002527/0001127602-19-002527-index.htm |
| 2019-01-28 | Lynne Powell | Senior VP - CCO | Buy | 2,000.00 | 3.22 | 6,440.00 | 2,000.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm |
| 2019-03-12 | STEVE ASELAGE | Director | Buy | 2,000.00 | 8.30 | 16,600.00 | 2,000.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219011361/0001127602-19-011361-index.htm |
| 2019-11-18 | STEVE ASELAGE | Director | Buy | 15,000.00 | 1.45 | 21,750.00 | 21,672.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219033001/0001127602-19-033001-index.htm |
| 2019-12-01 | STEVE ASELAGE | Director | Buy | 1,754.00 | 2.85 | 4,998.90 | 23,426.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219034168/0001127602-19-034168-index.htm |
| 2020-03-01 | STEVE ASELAGE | Director | Buy | 1,666.00 | 3.00 | 4,998.00 | 25,092.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760220009094/0001127602-20-009094-index.htm |
| 2020-06-01 | STEVE ASELAGE | Director | Buy | 1,112.00 | 4.50 | 4,998.44 | 26,204.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760220018719/0001127602-20-018719-index.htm |
| 2018-12-18 | William P Sheridan | Senior VP - CMO | Sell | 20,488.00 | 7.58 | 155,299.04 | 2,725.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760218036977/0001127602-18-036977-index.htm |
| 2019-09-01 | ROBERT ALEXANDER INGRAM | Director | Buy | 6,270.00 | 2.99 | 18,747.30 | 28,088.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219027858/0001127602-19-027858-index.htm |
| 2020-08-31 | STEVE ASELAGE | Director | Buy | 2,409.00 | 4.15 | 9,997.35 | 28,613.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760220024642/0001127602-20-024642-index.htm |
| 2019-01-16 | Lynne Powell | Senior VP - CCO | Buy | 3,046.00 | 3.22 | 9,808.12 | 3,046.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219002367/0001127602-19-002367-index.htm |
| 2019-01-28 | Lynne Powell | Senior VP - CCO | Buy | 4,000.00 | 3.22 | 12,880.00 | 4,000.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm |
| 2019-09-01 | Nancy J Hutson | Director | Buy | 3,344.00 | 2.99 | 9,998.56 | 43,046.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219027862/0001127602-19-027862-index.htm |
| 2019-11-18 | Megan Sniecinski | Chief Business Officer | Buy | 45,000.00 | 1.45 | 65,250.00 | 45,000.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219033033/0001127602-19-033033-index.htm |
| 2019-11-18 | ROBERT ALEXANDER INGRAM | Director | Buy | 20,000.00 | 1.45 | 29,000.00 | 48,088.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219033025/0001127602-19-033025-index.htm |
| 2019-05-22 | STEVE ASELAGE | Director | Buy | 3,000.00 | 3.57 | 10,710.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219019891/0001127602-19-019891-index.htm |
| 2019-11-18 | Nancy J Hutson | Director | Buy | 10,000.00 | 1.45 | 14,500.00 | 53,046.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219033022/0001127602-19-033022-index.htm |
| 2020-08-11 | Anthony Doyle | Chief Financial Officer | Buy | 54,000.00 | 4.08 | 220,320.00 | 54,000.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760220023449/0001127602-20-023449-index.htm |
| 2019-12-01 | ROBERT ALEXANDER INGRAM | Director | Buy | 6,578.00 | 2.85 | 18,747.30 | 54,666.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219034162/0001127602-19-034162-index.htm |
| 2019-12-01 | Nancy J Hutson | Director | Buy | 3,508.00 | 2.85 | 9,997.80 | 56,554.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219034165/0001127602-19-034165-index.htm |
| 2020-03-01 | Nancy J Hutson | Director | Buy | 3,333.00 | 3.00 | 9,999.00 | 59,887.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760220009065/0001127602-20-009065-index.htm |
| 2019-01-25 | Lynne Powell | Senior VP - CCO | Buy | 6,000.00 | 3.22 | 19,320.00 | 6,000.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219002873/0001127602-19-002873-index.htm |
| 2020-03-01 | ROBERT ALEXANDER INGRAM | Director | Buy | 6,250.00 | 3.00 | 18,750.00 | 60,916.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760220009058/0001127602-20-009058-index.htm |
| 2020-06-01 | Nancy J Hutson | Director | Buy | 2,224.00 | 4.50 | 9,996.88 | 62,111.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760220018711/0001127602-20-018711-index.htm |
| 2020-08-31 | Nancy J Hutson | Director | Buy | 1,204.00 | 4.15 | 4,996.60 | 63,315.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760220024646/0001127602-20-024646-index.htm |
| 2020-06-01 | ROBERT ALEXANDER INGRAM | Director | Buy | 4,171.00 | 4.50 | 18,748.65 | 65,087.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760220018704/0001127602-20-018704-index.htm |
| 2019-09-01 | STEVE ASELAGE | Director | Buy | 1,672.00 | 2.99 | 4,999.28 | 6,672.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219027867/0001127602-19-027867-index.htm |
| 2019-11-18 | THERESA HEGGIE | Director | Buy | 5,000.00 | 1.45 | 7,250.00 | 6,672.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219033017/0001127602-19-033017-index.htm |
| 2020-08-31 | ROBERT ALEXANDER INGRAM | Director | Buy | 4,518.00 | 4.15 | 18,749.70 | 69,605.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760220024637/0001127602-20-024637-index.htm |
| 2019-11-18 | Jon P Stonehouse | President & CEO | Buy | 50,000.00 | 1.45 | 72,500.00 | 778,086.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219033035/0001127602-19-033035-index.htm |
| 2019-12-01 | THERESA HEGGIE | Director | Buy | 1,754.00 | 2.85 | 4,998.90 | 8,426.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219034170/0001127602-19-034170-index.htm |
| 2019-01-14 | Lynne Powell | Senior VP - CCO | Buy | 954.00 | 3.22 | 3,071.88 | 954.00 | https://www.sec.gov/Archives/edgar/data/882796/000112760219002141/0001127602-19-002141-index.htm |